STERIS CORPORATION

Lobbying for STERIS CORPORATION

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Ohio · House · Senate · $100,000.00 expenses · posted Jul 20, 2026

Lobbying activity 3

Health Issues

FDA regulations and MDUFA Reauthorization

Manufacturing

Supply chain issues.

Trade (domestic/foreign)

Tariffs, USMCA

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem